基本信息
浏览量:80
职业迁徙
个人简介
Peter's recent research has centred on the cardiovascular complications of diabetes, specifically the role of modified proteoglycans in lipid deposition diseases such as atherosclerosis and most recently the molecular endocrinology of the signalling pathways controlling the synthesis and structure of the lipid-binding proteoglycan, biglcyan. . Peter has over 190 peer reviewed publications with an H factor of 46 (Google Scholar My Citations) and over 6200 citations. After a 20 year career at the as medical researcher and hospital scientist BakerIDI Heart and Diabetes Institute and Alfred Hospital, in 2010 Peter became the Foundation Head of Pharmacy at RMIT University, in Melbourne. In this context Peter added Pharmacy Practice to his research areas of interest. In June 2015, Peter became Head of the School of Pharmacy at The University of Queensland (UQ) and moved his research laboratory to the Pharmacy Australia Centre of Excellent (PACE) at UQ. UQ is ranked well inside the top 100 Universities in the world. Peter is Professor and Dean (Visiting) of the Dept. of Pharmacy at Xinhua College of Sun Yat-sen University.
研究兴趣
论文共 318 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Tingting Zhang,Mengmeng Zhu,Jialing Ma,Zhenghong Liu,Zhidan Zhang, Meijie Chen, Yaping Zhao,Huaxin Li,Shengnan Wang,Xiaoning Wei,Wenwen Zhang,Xiaoxiao Yang,
Journal of advanced research (2024)
Mei-jie Chen,Yi-tong Xu, Lu Sun,Zhi-hua Wang,Peter J. Little,Li Wang,Xun-de Xian,Jian-ping Weng,Suo-wen Xu
Hui Jiang, Yaping Zhao,Meiming Su, Lu Sun, Meijie Chen,Zhidan Zhang,Iqra Ilyas,Zhihua Wang,Peter J. Little,Li Wang,Jianping Weng,Jianjun Ge,
Pharmacological research (2024): 107029
Hui Jiang, Yaping Zhao,Meiming Su, Lu Sun, Meijie Chen,Zhidan Zhang,Iqra Ilyas,Zhihua Wang,Peter J. Little,Li Wang,Jianping Weng,Jianjun Ge,
PHARMACOLOGICAL RESEARCH (2024)
Acta Pharmacologica Sinicapp.1-12, (2024)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn